Slate Bio

company

About

Slate Bio is an immunotherapeutics development company that develops therapeutic solutions for autoimmune diseases.

Details

Last Funding Type
Seed
Last Funding Money Raised
$1.75M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2020
Operating Status
Active

Slate Bio is an immunotherapeutics development company that develops therapies that restore the body's natural immunological response in different diseases using bifunctional IL233 cytokine, thereby providing users with an independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.75M
Slate Bio has raised a total of $1.75M in funding over 2 rounds. Their latest funding was raised on Jan 19, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 19, 2021 Seed $1.75M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Slate Bio is funded by 1 investors. VTC Seed Fund are the most recent investors.
Investor Name Lead Investor Funding Round
VTC Seed Fund Seed